Skip to content
Home/Companies/Pharma/Pentapharm

Pentapharm

Pharma·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Pentapharm?

Pentapharm is currently owned by Orlando Management through Orlando Capital V (2024 vintage), since 2025.

Hand-verified · updated 2026-07-03

Orlando Management
Investor
Orlando Management
Orlando Capital V · 2024 · Turnaround

Key facts

HQSwitzerland
SectorPharma
StatusActive

More from Orlando Capital V

Other portfolio companies in the same fund.

Kwantum
Active
ConsumerNetherlands· 2026
Leen Bakker
Active
ConsumerNetherlands· 2026
Buerstadt Furniture
Buerstadt Furniture
Active
ConsumerGermany· 2025
LEICHT Kuechen
LEICHT Kuechen
Active
ConsumerGermany· 2025
Stockerpoint
Stockerpoint
Active
ConsumerGermany· 2025
Illig
Active
IndustrialsGermany· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Pentapharm

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Pentapharm?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Pentapharm.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue